Comparison of four different intraosseous access devices during simulated pediatric resuscitation. A randomized crossover manikin trial

European Journal of Pediatrics
Karol BielskiKurt Ruetzler

Abstract

The aim of the study was to compare the success rate, procedure time, and user satisfaction of pediatric NIO™ compared to Pediatric BIG®, EZ-IO®, and Jamshidi intraosseous access devices. This was a randomized, crossover manikin trial with 87 paramedics. The correct location of intraosseous access when using NIO, BIG, EZ-IO, and Jamshidi was varied and was respectively 100, 90, 90, and 90%. The time required to obtain intravascular access (time T1) in the case of NIO, BIG, EZ-IO, and Jamshidi was varied and amounted to 9 s [IQR, 8-12] for NIO, 12 s [IQR, 9-16] for BIG, 13.5 s [IQR, 11-17] for the EZ-IO, and 15 s [IQR, 13-19] for Jamshidi. The paramedics evaluated each device on the subjective ease with which they performed the procedures. The intraosseous device, which proved the easiest to use was NIO, which in the case of CPR received a median rating of 1.5 (IQR, 0.5-1.5) points. Our study found that NIO® is superior to BIG®, EZ-IO®, and Jamshidi. NIO® achieved the highest first attempt success rate. NIO® also required the least time to insert and easiest to operate even by novice users. Further study is needed to test our findings in cadavers or human subjects. Based on our findings, NIO® is a promising intraosseous device f...Continue Reading

References

Nov 11, 2005·Pediatric Emergency Care·Karen J L BlackDavid McGillivray
Oct 2, 2007·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Joe SuyamaDavid Hostler
Jan 24, 2008·Pediatric Emergency Care·Stephen M BlumbergEllen F Crain
Jun 24, 2009·The Journal of Emergency Medicine·Raemma P LuckColette C Mull
Jul 8, 2010·Journal of Emergencies, Trauma, and Shock·Guyon J Hill, Bruce D Adams
Jul 16, 2010·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Pamela LarsenRon Perkin
Jan 24, 2012·Clinical Pediatrics·J Routt ReigartTimothy H Hartzog
May 16, 2012·Circulation·Alexis A Topjian, Robert A Berg
Oct 10, 2013·The Western Journal of Emergency Medicine·Peter HallasLars Folkestad
Mar 26, 2014·Saudi Journal of Anaesthesia·Divya Sethi, Shalini Subramanian
Dec 3, 2014·The American Journal of Emergency Medicine·Andrzej KurowskiŁukasz Szarpak
Aug 25, 2015·Acta Anaesthesiologica Scandinavica·P K SuominenK Lauerma
Aug 26, 2015·JAMA : the Journal of the American Medical Association·Lars W AndersenUNKNOWN American Heart Association Get With the Guidelines–Resuscitation Investigators
Oct 20, 2015·Resuscitation·Ian K MaconochieUNKNOWN Paediatric life support section Collaborators
Apr 15, 2016·Critical Care : the Official Journal of the Critical Care Forum·F PetitpasO Mimoz
Jan 20, 2017·American Journal of Disaster Medicine·Elliot M RossDavid A Miramontes

❮ Previous
Next ❯

Citations

Apr 15, 2020·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society
Aug 15, 2018·Pediatric Emergency Care·Lukasz SzarpakKurt Ruetzler
Jan 13, 2021·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Morgan RecherStéphane Leteurtre
Mar 29, 2021·Resuscitation·Patrick Van de VoordeIan Maconochie
Jun 8, 2021·Notfall & Rettungsmedizin·Patrick Van de VoordeIan Maconochie

❮ Previous
Next ❯

Software Mentioned

Statistica
IO
SimJunior
StatSoft
Excel
EZ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.